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Abstract 
 
The gastric epithelium consists of different types of cells, which are involved in gastric 
homeostasis by balancing cell proliferation and differentiation. This process involves 
several signaling molecules such as growth factors, hormones and vitamins. Vitamin 
D3 (VD3) is engaged in several biological activities. It plays a role in cell 
differentiation, cell proliferation, immune response and also regulates calcium 
homeostasis. The biological activities of VD3 are mediated by vitamin D receptor 
(VDR). Target tissues of VD3 in the gastrointestinal tract were identified earlier in 
intestine, colon and gastric cancer tissues; however, the normal expression of VDR in 
stomach is poorly studied. So, the main objectives of this thesis are: 1) to investigate 
the normal expression, distribution and cellular localization of VDR in gastric 
epithelium and 2) to study possible role of VDR and VD3 in maintaining gastric stem 
cells proliferation and differentiation by establishing and analyzing mouse model 
deficient in VD3. Polymerase chain reaction (PCR) analysis showed that VDR as well 
as enzymes involved in VD3 metabolism are expressed in the different region of 
normal mouse stomach. Co-immunostaining analysis showed specific expression of 
VDR in the acid secreting parietal cells and the different mucus secreting cells. The 
results suggested that parietal cells and mucous cells are targets for VD3 signaling. To 
examine the role of VD3 on gastric homeostasis, wild type mice were put on VD3 
deficient diet for 3 months. Using Real-Time Polymerase Chain Reaction (Real-Time 
PCR), stomachs of mice deficient of vitamin D showed significant decrease in 
expression of parietal cell specific genes (HKα and HKβ) and increase gastrin gene 
expression. Moreover, quantification for cells in the S-phase of the cell cycle showed 
significant increase in their number in vitamin D deficient mice compared to controls. 
Gene expression analysis of VDR signaling genes showed significant decrease in 
PTHLH, but not other target genes like TRPV6 and p21. This work will add value to 
the field of stomach biology by providing better understanding of how VD3 and VDR 
are involved in maintaining gastric epithelial homeostasis and how that is related to 
some stomach conditions such as low gastric acidity and gastric cancer. 
 
Keywords: Vitamin D3, VDR, Gastric epithelium, Stem cell, Proliferation, 
Differentiation. 
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 )cibarA ni( tcartsbA dna eltiT
 
 دور مستقبلات فيتامين د في توازن الخلايا المعدية
 ملخصال
عن طريق  تتكون بطانة المعدة من عدة أنواع من الخلايا التي تساهم في الحفاظ على توازنها
م في هذه الموازنة بين تزايد أعداد هذه الخلايا و بين تمايزها الى خلايا أخرى متخصصة. تساه
 (DV3) امين ديلعب فيتالعملية العديد من الجزيئات: مثل عوامل النمو و الهرمونات و الفيتامينات. 
 تزايدهاتيلعب دوًرا في تمايز الخلايا و حيث، دوراً مهما ً في العديد من الانشطة البيولوجية
بيولوجية النشاطات التوازن الكالسيوم في الجسم. يتوسط هذه والاستجابة المناعية وينظم أيًضا 
بحاث . من خلال الا )RDV( فيتامين د تمستقبلاتعرف بمستقبلاتها الخاصة والتي  لفيتامين د
الأمعاء و والتي تتمثل ب الجهاز الهضمي ستهدفة من فيتامين د فيتم تحديد الأنسجة المالسابقة 
دراسته بشكل  القولون والانسجة السرطانية في المعدة، ولكن دور هذه المستقبلات في المعدة لم يتم
امين د فيت ن تواجد مستقبلاتالتحقق م) 1: كافي. تتمحور الأهداف الرئيسة لهذه الأطروحة حول
الخلايا ن توازفي الحفاظ على دور مستقبلات فيتامين د ) دراسة 2في أنسجة وخلايا المعدة وأيضا 
غ صببعض التقنيات مثل  تطبيق عن طريق تمايزهاو للمعدة، من حيث تزايد أعدادهاالجذعية 
ل ) و دراسة معدyrtsimehcotsihonummIأنسجة المعدة بأنواع خاصة من الأجسام المضادة (
نقص لفئران تعاني من ذج نمو ). من خلال استخدامRCP emiT-laeRتغير بعض الجينات (
ي عملية ف المشاركةبالإضافة إلى الإنزيمات مستقبلات فيتامين د  أظهرت نتائجنا أند  فيتامين
واجد تير في أظهرنا انخفاض كبمعدة. كما في أجزاء المختلفه من ال تكوين فيتامين د تتواجد
الحمض  ارتفاع و )αKH(و  )βKH) للجينات (ANRmالحمض النووي الرايبوزي من النوع (
على  وعلاوةد. نقص فيتامين  التي تعاني من في الفئران) nirtsag( النووي الرايبوزي للجين
تراجع  أيضا والجذعية ذلك ، أظهرت النتائج التي توصلنا إليها زيادة كبيرة في عدد الخلايا 
) فقط في HLHTP، 12p،  6VPRT(د مثل  عض الجينات المستهدفة من فيتامينالنسبيي لب
خلال  من الأبحاث قلحسيضيف هذا العمل قيمة إلى التي تعاني من نقص في فيتامين د.  الفئران
 لجذعيةافي الحفاظ على توازن الخلايا  فيتامين د و مستقبلات فيتامين د يفية مشاركةك توضيح
في المعدة وكيف يرتبط ذلك ببعض الحالات الصحية مثل انخفاض حموضة المعدة وسرطان 
 المعدة.
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لايا الجذعية، ة المعدة، الخفيتامين د، مستقبلات فيتامين د، خلايا بطان : مفاهيم البحث الرئيسية
 الخلايا، تمايز الخلايا. تزايد
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Chapter 1: Introduction 
1.1 Overview 
Vitamins are organic compounds with several metabolic functions, they are 
distinct from minerals, amino acids and fatty acids [1]. Vitamins are nutritional factors, 
naturally present in the diet, required in small quantities and essential for the body to 
perform its ordinary physiological functions such as growth, reproduction and 
maintenance. It is remarkable to realize that not all vitamins are found in diet, some of 
them need further activation in our body to be converted into their functional form. 
There are various types of vitamins such as vitamin A, vitamin B1, vitamin B2, vitamin 
B6, vitamin B12, vitamin C, vitamin D, vitamin E, vitamin K, Niacin, Biotin, Folic 
acid and Pantothenic acid [2].   
Some of these vitamins such as biotin and vitamin B6 act as coenzymes for 
carboxylations, fatty acid metabolism or amino acid metabolism [2]. Moreover, 
vitamin A is essential for the growth and eye vision [3]. 
The classical effect of vitamin D is very much connected to bone structure and 
regulation of calcium homeostasis [4]. Nevertheless, vitamin D is also involved in 
several cellular processes, such as cell differentiation [5] and proliferation [6]. 
Moreover, vitamin D contributes significantly to many physiological functions like 
pancreatic secretion of insulin [7], in cardiovascular system [8] as well as immune 
response [9].  
This introductory chapter is shedding light on vitamin D3 and vitamin D 
receptor. It begins with brief historical overview of vitamin D, followed by description 
of its structure, metabolism process as well as how its function is meditated by vitamin 
D receptor. The role of the ligand and its receptor in health and disease will be 
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illustrated as well. Furthermore, throughout the chapter the expression and the function 
of vitamin D receptor in gastrointestinal tract and other tissues will be demonstrated.  
1.2 Vitamin D 
The early discovery of vitamin D started with a series of experiments aimed to 
study rickets disease; which is defective calcification of bones, in different models. A 
classical experiment conducted by Edward Mellanby involving two months old 
puppies which were provided with specific diet known to produce rickets. Another 
group of puppies was fed the same diet in addition to other kinds of food such as meat, 
malt extract, butter, yeast extract and cod liver oil. The puppies were kept indoor 
inadvertently. The observation was that the group of puppies fed diet with cod liver oil 
or butter didn’t develop rickets at all Rickets was diagnosed by using X-ray. The 
conclusion of this work was that the presence of certain fat-soluble accessory factors 
such as cod liver oil or butter in the diet can prevent rickets disease [10].  
McCollum also discovered earlier that some fats contain dietary substances 
which are involved in the growth process [3]. In 1919, he found that cod liver oil 
contains substance which could prevent rickets and named it vitamin D [11].    
Other than the supplementary factors in the diet, Harriette Chick and her 
colleagues [12] as well as other researchers [13] demonstrated the effect of sunlight in 
curing rickets in children. So the dominated idea at that time was that some dietary 
factors such as cod liver oil and sunlight can attribute in preventing and curing rickets. 
Furthermore, to investigate whether the fatty dietary factors from plants represented 
by phytosterol can have anti-rachitic effect just like animal fat (i.e. cod liver oil) as 
noticed earlier, Alfred Hess and his team prepared rickets producing diet along with 
phytosterol extracted from cottonseeds. A group of rats was fed an UV-irradiated 
3 
 
extract of this diet, while another group was fed non-irradiated extract. The same 
experiment was repeated by using cholesterol extracted from brain tissue. They noticed 
that the group of rats which had irradiated phytosterol or cholesterol didn’t produce 
rickets disease unlike the other group, concluding that the irradiation of the fatty 
substance is a critical step for the rickets prevention. Furthermore, they hypothesized 
that cholesterol which is present in our skin cells can be converted to the active form 
of cholesterol by UV irradiation, and then circulated in the body in order to prevent 
rickets [14]. Thereafter, it was discovered that the precursor molecule is not 
cholesterol, but in fact another impurity found within the cholesterol which acts as 
anti-rickets factor and was named as provitamin [15]. Moreover, the provitamin should 
be irradiated by UV light to be converted to vitamin D [16].  
1.2.1 Vitamin D2 and Vitamin D3 
Vitamin D is widely described as hormone since it is derived from pro-steroid.  
There are two different forms of vitamin D: Vitamin D2 , Ergocalciferol [17] and 
Vitamin D3 , Cholecalciferol [18]. Ergocalciferol is a plant based form of vitamin D, 
it is derived from the provitamin ergosterol which is converted into ergocalciferol by 
UV irradiation [17]. 
On the other hand, Cholecalciferol is produced in the epidermis of animals and 
humans by the photolysis of the sterol precursor; 7-dehydrocholesterol [18]. 
Ergocalciferol and Cholecalciferol have slight differences in their structure. The 
absence of double bond between C22 and C23 and absence of methyl group at C24 in 
Cholecalciferol lead to a distinct side chain for each of vitamin D forms (Figure 1.1). 
However, both can be converted to 25-hydroxyvitamin D [18], [19].  
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Figure 1.1: Molecular structure of the two forms of vitamin D. 
(A) Ergocalciferol (B) Cholecalciferol. Ergocalciferol is characterized by having 
double bond between C22 and C23 and methyl group at C24 [18]. 
 
1.2.2 Vitamin D Metabolism 
Ergocalciferol and Cholecalciferol can be obtained from dietary sources, 
however, the main source of Cholecalciferol is the skin. The provitamin molecule; 7-
dehydrocholesterol is naturally present in animal cells, specifically in the skin, and 
works as precursor for Cholecalciferol. After the exposure to sunlight, ultra-violet 
radiation B (UV-B) converts 7-dehydrocholesterol to previtamin that has unstable 
structure and consequently isomerizes to form Cholecalciferol in the plasma 
membrane of the skin cells. As Cholecalciferol leaves the plasma membrane to the 
extracellular fluid space, it binds to Vitamin D Binding Protein (DBP) in the blood 
stream for translocation [20]. Illustration of vitamin D activation is demonstrated in 
(Figure 1.2). 
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Figure 1.2: Vitamin D3 synthesis pathway. 
UVB radiation converts 7-dehydrocholesterol to Cholecalciferol through 
photochemical reaction. CYP2R1 and CYP27A1 enzymes synthesize 25-
hydroxyvitamin D3 (25(OH)D3) from Cholecalciferol in liver. 25-hydroxyvitamin D3 
(25(OH)D3) is translocated to kidney to be further synthesized to the active form of 
vitamin D3; 1α,25-dihydroxyvitamin D3 (1α,25(OH)2D3) by the enzyme CYP27B1. 
 
Thereafter, Cholecalciferol is translocated to the liver where the enzymes 25-
hydroxylase (CYP2R1) and sterol 27-hydroxylase (CYP27A1) convert 
Cholecalciferol to 25-hydroxyvitamin D3 (25(OH)D3). As 25(OH)D3 is synthesized, it 
is transported mainly to the kidney via DBP where it is further hydroxylated to produce 
the biologically active form of VD3; 1α,25-dihydroxyvitamin D3 (1α,25(OH)2D3) by 
the enzyme 1α-hydroxylase (CYP27B1); an enzyme mainly expressed in the kidney. 
Then 1α,25(OH)2D3 travels to vitamin D target tissues such as bone and intestine to 
perform its biological functions which are mediated by Vitamin D Receptor (VDR) 
(Figure 1.2) [21]. 1α,25(OH)2D3 is lipophilic steroid hormone with long and flexible 
structure [22].  
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As demonstrated earlier, there are distinct key proteins involved in vitamin D 
metabolism, these proteins include some cytochrome P450 enzymes (CYPs) as well 
as DBP. Cytochrome P450 2R1 enzyme (CYP2R1), also known as vitamin D 25-
hydroxylase is encoded by the gene CYP2R1, this microsomal hepatic enzyme has 
vitamin D 25-hydroxylase activity and it is the major contributor to 25(OH)D3 
synthesis [23], [24]. Zhu et al showed that more than 50% decline in serum 25(OH)D3 
level and steady level of serum 1α,25(OH)2D3 in CYP2R1-/- mice comparing to wild 
type. These knockout mice had no other serious health problems [24]. While in human, 
mutation in CYP2R1 gene developed symptoms of vitamin D-dependent rickets in 
children as illustrated in a clinical study [25].  
Cytochrome P450 27A1 enzyme (CYP27A1) which commonly known as 
sterol 27-hydroxylase is mitochondrial hepatic enzyme primarily responsible for bile 
acid formation [26]. Additionally, this enzyme also has the ability to stimulate the 
conversion of Cholecalciferol to 25(OH)D3 by hydroxylation [27]. In a previous study, 
CYP27A1-/- mice experienced disruption in bile acid formation process and normal 
vitamin D metabolites level [28]. Suggesting that CYP27A1 enzyme might be a minor 
contributor in 25(OH)D3 formation.   
Concluding, CYP2R1 and CYP27A1 which has different hepatic intracellular 
localization are engaged in the enzymatic hydroxylation of Cholecalciferol to produce 
25(OH)D3 in liver. 
1α-hydroxylase (CYP27B1) is another enzyme from Cytochrome P450  super-
family, expressed in the proximal tubules of kidney, interestingly CYP27B1 is the sole 
enzyme responsible for synthesizing 1α,25(OH)2D3  [21]. On the other hand, the 
activity of CYP27B1 can be suppressed by  serum 1α,25(OH)2D3 [29] as well as high 
calcium levels in blood [30].  
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Interestingly, 1α,25(OH)2D3 and 25(OH)D3 degradation is initiated by 
Cytochrome P450 24 A1 enzyme (CYP24A1); 24-hydroxylase when necessary [31]. 
This enzyme is responsible for the catabolism of vitamin D, as it is capable of C24 or 
C23 site hydroxylation. One of the final products of 1α,25(OH)2D3 catabolism is 
calcitroic acid; as a result of C24  hydroxylation [32].   
Several studies showed that the expression of these enzymes is not specific for 
the liver and kidney. In vitro studies illustrated that CYP27B1 is expressed in HaCaT 
keratinocytes [33], macrophages [34] as well as bone [35]. While CYP2R1, CYP24A1 
and CYP27B1 are expressed in placenta [36].  
Another important protein in vitamin D metabolism and action is DBP. DBP 
is from Group specific component proteins, this plasma protein has the ability to bind 
to vitamin D and its metabolites serving  in transporting them between tissues through 
blood stream [37].    
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Table 1.1: Molecules involved in vitamin D3 synthesis 
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1.3 Vitamin D Receptor 
The biological activities and functions of 1α,25(OH)2D3 are mediated by VDR. 
VDR is a member of nuclear receptors family; member 1 from nuclear receptor 
subfamily 1, group I [38]. The function of VDR is highly correlated with its structure 
and molecular nature. VDR has two conserved binding domains, Ligand Binding 
Domain (LBD) and DNA Binding Domain (DBD) [39].  
LBD represents the site where 1α,25(OH)2D3 or its analogs can bind, 
heterodimerization with Retinoid X Receptor (RXR) occur and VDR-mediated 
transcription activation take place throughout ligand-dependent transactivation 
Function domain (AF-2). Whereas DBD is involved in the process of target genes 
activation through the direct binding to the DNA via two zinc fingers [39], [40]. In 
addition to these conserved domains, there are ligand-independent transactivation 
function domain (AF-1) and Hinge domain which allow flexible rotation for the 
receptor [40] (Figure 1.3).  
 
Figure 1.3: Graphic representation of VDR structure. 
AF-1 is toward N terminus site. DBD contains two zinc fingers which allow proper 
binding to target genes. Hinge Domain provide rotational flexibility of VDR. ligands 
and RXR bind to LBD, while coactivators interaction take place at AF-2 site. 
 
Interestingly, VDR-LBD has two overlapping pockets; Genetic Pocket (GP) 
(which is responsible of genetic responses when VDR acts as transcription factor), and  
Alternative Pocket (AP) (which is involved in rapid responses [41] such as chloride 
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channel regulation [42] and rapid intestinal calcium absorption) [43]. The activation 
of VDR results from binding of 1α,25(OH)2D3 to either pockets [44]. 
1.3.1 Mechanism of Action 
Throughout this thesis, the active form of VD3 will be stated as 1α,25(OH)2D3.  
VDR serves as ligand-dependent transcription factor when 1α,25(OH)2D3 binds to the 
GP, leading to an interaction between the complex 1α,25(OH)2D3 and VDR with 
another receptor know as Retinoid X Receptor (RXR). That interaction drives to 
1α,25(OH)2D3-VDR-RXR heterodimer formation. The heterodimerized complex 
travels to the nucleus where it recognizes and binds to Vitamin D Response Elements 
(VDREs) located in the promoter of vitamin D direct target genes. As a result, the 
activated VDR induces coactivators or corepressors to regulate the transcription of the 
target genes directly (Figure 1.4). The transcription of these genes leads to the 
production of proteins responsible for mediating the genetic functions of VDR 
[44],[45]. VDREs is made up of two half-sites of similar, but not identical six 
nucleotides separated by three nucleotides spacer [46].    
VDR is also considered plasma membrane receptor, since it is associated with 
the plasma membrane caveolae initiating rapid response (non-genetic mechanism). As 
soon as the ligand binds to the AP, a rapid signal transduction pathways will be 
activated such as rapid absorption of Ca2+ [44].  
The ability of one ligand to induce two different responses when binding to a 
single receptor is centered around the capability of 1α,25(OH)2D3 to undergo 
conformational changes due to its flexible structure [47]. 
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1.3.2 Vitamin D Target Genes 
The biological responses toward VD3 are mediated by VDR. 1α,25(OH)2D3 
regulates transcription of several genes through VDRE on the promoter of these target 
genes. Example of these target genes is Transient Receptor Potential Vanilloid member 
6 (TRPV6), which is Ca2+ channel that plays a role in Ca2+ uptake in GI tract [48]. 
Chow et al. illustrated that capsaicin can induce apoptosis in gastric cancer cells 
through TRPV6 mediated mechanism [49]. Parathyroid Hormone Like Hormone 
(PTHLH) is another gene which is transcriptionally regulated by 1α,25(OH)2D3 [50]. 
PTHLH is involved in chondrocyte cells differentiation and proliferation and bone 
resorption [51].    
Moreover, Cyclin-Dependent Kinases Inhibitor (p21); a tumor suppressor that 
cause cell cycle arrest is regulated by 1,25(OH)2D3 [52]. 1,25(OH)2D3 has 
antiproliferative activities by modulating the expression of p21 via VDREs and further 
having cell cycle regulatory effect [53].   
Cathelicidin Antimicrobial Peptide (CAMP) gene is another vitamin D target 
gene with VDREs [54]. These small peptides are stored in granules produced by 
neutrophils in the skin and other tissues. They play an essential role in immune 
response against viral and bacterial infection [55].    
Moreover, cytochrome P450 3A4 (CYP3A4) is a gene expressed in liver as well 
as intestine, directly regulated by vitamin D through VDREs [56]. CYP3A4 is mainly 
involved in breaking down the toxic agent; secondary bile acid Lithocolic Acid (LCA). 
This detoxification role of CYP3A4 is modulated by pregnane X receptor and nuclear 
xenobiotic [57]. Furthermore, 1,25(OH)2D3 is a potent and direct inducer of RANKL 
gene expression in osteoblastic cells  [58]. The heterodimer VDR and   act one RANKL 
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promoter initiated osteoclast differentiation supporting its survival, and consequently 
enhancing bone resorption [58].         
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Table 1.2: Some vitamin D3 target genes 
Target Gene Function Reference 
PTHLH Parathyroid Hormone 
Like Hormone 
Involved in stimulating bone 
resorption. Induce 
myorelaxant effects in smooth 
muscles of different organs. 
[59] 
TRPV6 Transient Receptor 
Potential Vanilloid 
member 6 
Highly Ca2+ selective channel 
protein that plays major role 
in Ca2+  uptake in kidney and 
gastrointestinal tract. 
[48] 
p21 Cyclin-Dependent 
Kinases Inhibitor 
Tumor suppressor, that cause 
cell cycle arrest, by inhibiting 
the cells to enter S phase.  
[60] 
CAMP 
 
Cathelicidin 
Antimicrobial Peptide 
Peptide agent protective 
against microbial infections, 
produced by neutrophils in 
skin, aquamouse epithelial on 
mouth, vagina and other 
tissues.    
 
[55] 
CYP3A4 Cytochrome P450 3A4 Detoxification, by breaking 
down the hepatotoxic acid; 
Lithocholic Acid.  
 
[56] 
RANKL Receptor Activator of 
Nuclear factor Kappa-Β 
Ligand 
Essential for bone resorption. [58] 
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Figure 1.4: VDR genetic and non-genetic mechanisms. 
For the genetic action, the ligand 1α,25(OH)2D3 binds to VDR, then the complex 
interact with RXR leading to form heterodimer. VD3-VDR-RXR heterodimer travel to 
the nucleus where it recognizes VDREs of the target gene and binds there inducing 
coactivators or corepressors to regulate the transcription. For the non-genetic action, 
1α,25(OH)2D3 binds to VDR which is associated with the plasma membrane caveolae 
inducing rapidly response (Modified from [61]).   
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1.4 Vitamin D and VDR in Health and Disease 
It is well known that vitamin D plays a major role in maintaining calcium 
homeostasis and bone health. In addition, researchers were very much interested to 
study the non-skeletal actions of vitamin D, showing evidence that vitamin D status 
and VDR are associated with multiple biological responses such as cell proliferation 
[6], differentiation [62]. Vitamin D is also important for in the nervous system, 
immune system [62] and cardiovascular system [63].  
1.4.1 Calcium Homeostasis 
The classical action of vitamin D is to maintain calcium (Ca2+) and phosphorus 
(P) serum levels and bone mineralization. Once serum Ca2+ level decreases, 
Parathyroid Hormone (PTH) is released acting on kidney to decrease loss of Ca2+ in 
urine. Moreover, PTH acts on stimulating bones to mobilize Ca2+ from it and send it 
directly to the blood. In addition to that, 1α,25(OH)2D3 can directly bind to VDR on 
intestine leading to Ca2+ and P uptake. Finally these actions return Ca2+ to its normal 
level [4]. 
1.4.2 Cell Differentiation 
Far beyond the classical action, vitamin D can induce cell differentiation. 
Wang et al showed that 1α,25(OH)2D3 has the ability to induce differentiation of 
monocyte of human myeloid cells in HL60 cells. 1α,25(OH)2D3 increased the 
expression of Kinase Suppressor Of Ras 1 (KSR-1) gene which has VDREs, 
stimulating monocytic differentiation [62]. 
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1.4.3 Cancer 
Studies with system models of lung cancer [64], prostate cancer [65], breast 
cancer [66] as well as hyperplasia of parathyroid gland [6] showed that 1α,25(OH)2D3 
has anticancer effects by down-regulating the hyper-proliferative cells and promoting 
apoptosis. Additionally, patients with pancreatic ductal adenocarcinoma showed 
upregulation of CYP24A1 mRNA in malignant tissues comparing to nonmalignant 
tissues of the pancreas. As a result, reducing the antiproliferative effect of 
1α,25(OH)2D3 in malignant tissues [67].  
1.4.4 Nervous System 
Knowing that VDR is expressed in neurons [68], [69], [70], recent studies 
suggested that some neurodegenerative diseases such as Alzheimer, Parkinson and 
multiple sclerosis diseases are linked to Vitamin D deficiency [71]. These 
neurodegenerative diseases are characterized by increased Ca2+ signaling [71]; and 
since vitamin D controls the expression of Ca2+  regulating proteins [72], progress of 
these diseases might be expected when there is low vitamin D in the body. 
1.4.5 Cardiovascular System 
Some studies demonstrated that low vitamin D levels due to insufficient UV 
light intensity and dysregulation of the reactive oxygen species and Ca2+ signaling may 
contribute to the pathogenesis of some cardiovascular diseases such as hypertension, 
cardiac hypertrophy, congestive heart failure and atrial arrhythmias [63], [71].  
1.4.6 Depression 
In psychiatric conditions, vitamin D deficiency or insufficiency has been 
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studied in depression cases. Milaneschi et al Showed association between 25(OH)D 
serum level and depression in a study which involved group of individuals (1,102 with 
current depressive disorders, 790 with previous depressive disorders, 495 control) 
aged 18-65 years. The investigation showed lower 25(OH)D serum level among the 
individuals with current depressive disorders as compared with the other groups [73]. 
1.4.7 Hair Loss 
Moreover, studies in animals and human reported that vitamin D is linked to 
hair loss. Xie et al demonstrated that lack of VDR affected hair growth by inhibiting 
keratinocyte differentiation; consequently, preventing keratin lament bundles 
formation in VDR knockout mouse. The phenotypes included expansion of hair 
follicle with dermal cysts formation causing complete alopecia with time [74].  
Furthermore, a study done on 80 females age between 18 to 45 years old with 
hair loss disease; female pattern hair loss (FPHL) or chronic telogen effluvium (TE), 
showed that vitamin D2 serum level was significantly lower in these females compared 
to control group [75].   
1.4.8 VDR Polymorphysims 
In human, alterations in DNA sequence of VDR gene can cause major defects 
in the gene activities. Point mutation in VDR gene has been linked to heredity vitamin 
D-resistant rickets which is famous with insensitivity to 1α,25(OH)2D3  by the target 
tissues [76].  
Diabetes Mellitus which is an endocrine-chronic disease has been also linked 
to VDR polymorhysims. Early studies showed that in pancreas, insulin producing β 
cells are expressing VDR [77]. Interestingly, it was found that insulin secretion reduced 
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in VDR mutant mice [78] concluding that VDR plays a role in insulin secretion 
process.  
Moreover, an epidemiological study demonstrated an association between low 
vitamin D level and decreased insulin sensitivity in healthy group with specific VDR 
polymorphysim [79]. Another study had linked type 1 diabetes mellitus and  BsmI-
VDR polymorphysim among diabetic Taiwanese population [80].   
Furthermore, it was described that VDR polymorphisms has been associated 
with secondary hyperparathyroidism in chronic renal failure, some cancers such as 
breast and colon as well as some autoimmune diseases [81].  
1.5 VDR in Gastrointestinal Tract 
Target tissues of vitamin D throughout the gastrointestinal tract (GI tract) were 
identified earlier in different animal models [82]. Animals injected with radiolabeled 
1α,25(OH)2D3  followed by microscopic autoradiography examination showed many 
ligand binding sites in the small intestine, stomach and colon [82]. 
VDR expression was reported in several tissues along the GI tract of normal 
human and animals [83]. Using in situ hybridization and immunohistochemistry, small 
intestine showed abundant distribution of VDR from duodenum to ileum. Moreover, 
VDR expression was observed in normal colonic epithelial cells [84]. In stomach, 
isthmus region in corpus and scattered cells in pyloric antrum were identified as target 
tissues of 3H-1α,25(OH)2D3 [82] Columnar mucosa as well as Submucosal glands and 
ducts of the human gastroesophageal junction showed positive immunofluorescence 
to VDR [85]. 
Stating about cancerous tissue, VDR was poorly expressed in malignant gastric 
tissue [86] and Barrett’s esophagus [85] when compared to normal tissues, suggesting 
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that loss of VDR activity is associated with malignancy. Interestingly, the non-
malignant gastric tissues, premalignant gastric tissue and malignant gastric tissue were 
expressing VDR in different levels. For example, the moderately differentiated 
premalignant gastric tissues highly expressed VDR comparing to the poorly 
differentiated premalignant gastric tissue [86], [85].  
Therefore, being aware of the normal distribution of VDR in normal gastric 
tissue might assist in diagnosing and assessing gastric cancer.    
1.6 Mouse Gastric Epithelium 
In human, the stomach is divided anatomically into three main parts, Fundus, 
Body and Pyloric antrum. These parts are existing in mouse as Forestomach, Corpus 
and Antrum respectively [87], [88]. The epithelial lining of the corpus and antrum are 
buildup of long tubular gastric epithelial glands, which consists of different epithelial 
cells [89].  
The building block of the glandular part is the gastric gland. The corpus gastric 
gland has four unique regions named as Pit, Isthmus, Neck and Base, each one of these 
regions is consist of dynamic epithelial cells. For instance, in the Pit region, surface 
mucus cells which secret mucus are mainly located. The Isthmus region has stem cells 
which has the ability to differentiate and give rise to any of the corpus gland cells. 
Mucus neck cells which are also mucus secreting cells are located in the Neck region. 
Parietal cells which secret hydrochloric acid are well characterized rounded cells 
scattered in the Isthmus, Neck and Base region. Zymogenic cells (also known as chief 
cells) which secrete pepsinogen, and Enterochromaffin-like cells (ECL) which 
produce histamine are located in the Base region [87], [90].  
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The components of the antral gastric gland are surface mucus cells in the Pit 
region, deep mucus cells, gastrin producing G cells, somatostatin producing D-cells 
and antral stem cells which are located in the Base [91], [92]. 
All the above mentioned cells originate from the gastric epithelial stem cells 
and their distribution vary in the different parts of the stomach [89]. Therefore, the 
gastric glands in the corpus and antrum are histologically different as detailed in 
(Figure 1.5).   
Gastric epithelial homeostasis is maintained by the gastric stem cells. These 
cells not only have the ability to differentiate and give rise to any gastric epithelial cell, 
but also continuously regenerate and renew the gastric epithelium [89], [93].  
Although previous studies linked VDR signaling to Ca2+ activity and cancer 
progress, the normal function of VDR in the stomach and how it can be involved in 
gastric homeostasis is unrevealed.  
 
  
21 
 
 
 
 
 
 
Figure 1.5: Mouse and human stomach anatomy. 
The stomach consists of three sections, forestomach/fundus, corpus and antrum. The 
corpus and antrum are glandular units buildup of differentiated and undifferentiated 
cells (Modified from [94]). the corpus gastric gland is divided into 4 regions, Pit, 
Isthmus, Neck and base.  while the antral gastric gland is shorter and consist of two 
regions; Pit and Gland.   
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1.7 Thesis Objectives and Hypothesis 
Based on the literature review provided in early sections, the early discovery 
of vitamin D was after series of experiments linked to Rickets disease. However, late 
studies showed that vitamin D has substantial contribution at several biological 
activities. 
 As the intestine and other tissues in GI tract are expressing VDR, the 
expression and the role of this nuclear receptor in gastric epithelium is not well studied.  
The goals of my Master Thesis were to identify the normal expression, 
distribution and cellular localization of VDR in gastric epithelium of C57BL/6J mice. 
Further, to study the expression of the enzymes (CYP2R1, CYP27A1, CYP27B1, 
CYP24A1) involved in vitamin D metabolism.  
Since gastric epithelial homeostasis is maintained by gastric stem cells 
proliferation and differentiation, this thesis aims also to find the role of VDR in this 
process. This will be achieved by demonstrating the long term effect of low serum 
vitamin D on gastric epithelium VDR expression mice.  
As the hypothesis was that VDR is involved in maintaining gastric epithelial 
cell proliferation and differentiation, Immunohistochemistry, RT-PCR and Real-Time 
PCR techniques were applied to support it. 
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Chapter 2: Methods 
2.1 Animals 
This study was approved by the Ethics committee of the United Arab Emirates 
University (UAEU). C57BL/6J mice were hosted in Specific Pathogen Free (SPF) 
environment at the animal facility of Faculty of Medicine and Health Sciences of 
UAEU.  
After weaning at 3 weeks old, the mice were divided to 3 groups based on the 
diet and light exposure as the following: 
 
Table 2.1: Diets and light/dark conditions 
Group No. Diet Light Cycle 
Group 1: 
(SDL) 
Standard diet: 
Standard AIN-93G Rodent Diet with 
1000 IU VD3 
(D10012Gi, Research Diet) 
12 hr light/dark 
Group 2: 
(SDD) 
Standard diet: 
Standard AIN-93G Rodent Diet with 
1000 IU VD3 
(D10012Gi, Research Diet) 
No overhead light 
Group 3: 
(VDD) 
VD3 deficient diet: 
AIN-93G Growing Rodent Diet with 25 
IU VD3/kg of diet 
(D17053003i, Research Diet) 
No overhead light 
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The mice were kept in the previous conditions for 3 months, the weight was 
recorded on a weekly basis. The animals were fasted over night before dissection. 
Blood was collected for serum analysis and stomach tissue for IHC and Real-Time 
PCR. 
2.2 Histological Analysis 
The collected gastric tissues were fixed by Bouine fixative for 24 hrs, followed 
by 70% ethanol and then processed, paraffin embedded and sectioned (5 µm). After 
that the sections were deparaffinized and rehydrated for hematoxylin and eosin, 
immunoperoxidase staining or immunoflurescent staining. Slides were imaged using 
Olympus microscope IX83. 
2.2.1 Immunohistochemistry 
For immunoperoxidase staining, heat induced antigen retrieval was applied and 
then all the sections were pretreated with 3% H2O2 to inhibit endogenous peroxidase 
activity. The sections were incubated with 1% Bovine Serum Albumin (blocking 
reagent) for 1 hr. Rat polyclonal to anti-VDR antibody (ab115495, abcam, dilution 
1:150) was incubated overnight at 4 °C and then biotin-SP conjugated goat anti-rat 
IgG (H+L) (112-065-003, Jackson immunoresearch, dilution 1:1000) was used at 
room temperature for 1 hr incubation. After PBS wash, sections were incubated with 
Extravidin-Peroxidase at dilution 1:1000 in blocking reagent at room temperature 
followed by another PBS wash. After that DAB: UREA (1:1) was added to sections 
for 6 min then washed twice using distilled water and counterstained with 
hematoxylin. The slides were dehydrated prior mountining with DPX. 
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Same protocol was follow for peroxidase staining of parietal cells using rabbit 
polyclonal to anti-H+K+ATPase-β primary antibody (ab176992, abcam, dilution 
1:100) and 2 min incubation with DAB: UREA (1:1). 
For 5-bromo-2’-deoxyuridine (BrdU) staining, mice were injected with 120 
mg/kg BrdU (B5002, Sigma Aldrich) prepared in sterile distilled water. Intraperitoneal 
injection was given 2 hours prior sacrifice. The sections were incubated with mouse 
monoclonal to anti-BrdU antibody (MI-11-3, MBL Life Science, dilution 1:500) 1 
hour at 4 °C and then followed by 1 hour incubation with biotin-SP conjugated goat 
anti-mouse IgG (H+L) (115-065-003, Jackson immunoresearch, dilution 1:500). 
2.2.2 Multi-label Immunofluorescence 
For co-immunofluorescence staining, PBS wash and permeabilization using 
0.1% triton X-100 in PBS were performed after heat induced antigen retrieval. Then 
sections were incubated with 1% Bovine Serum Albumin (blocking reagent) for 1 hr 
and subsequently incubated overnight at 4 °C with anti-VDR primary antibody raised 
in rat (ab115495, abcam, dilution 1:150). Sections were washed with PBS three times 
for 5 min and then fluorescent goat anti-rat secondary antibody (112-165-003, Jackson 
ImmunoResearch, dilution 1:500) incubated at room temperature for 1 hr were used, 
followed by another PBS wash.  
Parietal cell marker; rabbit polyclonal to anti-H+K+ATPase-β primary antibody 
(ab176992, abcam, dilution 1:100) was incubated along with anti-VDR primary 
antibody to detect the expression of VDR in parietal cells. While, lectins UEA-l-
Rhodamine (RL-1062) and GSII (L21415, Life Technologies) were incubated with the 
fluorescent goat anti-rat secondary antibody for surface mucus cells and neck mucus 
cells detection, respectively. Secondary antibodies used were Cy3-conjugated goat 
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anti-rat IgG (H+L) (112-165-003, Jackson ImmunoResearch), Alexa Fluor 448-
conjugated goat anti-rat IgG (H+L) (112-545-003) and goat anti-rabbit IgG H&L 
(TRITC) (ab6718, abcam). 
Mounting media with 4′,6-diamidino-2-phenylindole (DAPI) for nuclei 
counterstaining was used and finally coverslip was placed. Negative control was 
prepared for each experiment by excluding the primary antibodies. 
2.3 RNA Isolation 
Total RNA was isolated from different parts of the mice stomach (forestomach, 
corpus and antrum) using RNeasy Mini Kit (Qiagen). RNA clean-up was performed 
using RNase-Free DNase set (Qiagen) as recommended by the manufacturer. To 
synthesize cDNA, 1µg of RNA was reverse transcribed using iScript™ cDNA 
synthesis kit (Bio-Rad). 
2.4 Reverse-Transcription PCR 
To study the expression of VDR, CYP2R1, CYP27A1, CYP27B1 and CYP24A1 
in normal mouse gastric tissue, Reverse-Transcription PCR was conducted with the 
earlier synthesized cDNA using GoTaq Flexi DNA Polymerase kit (Promega) and 
using specific primers as detailed in table (2.1). 
PCR product was separated by gel electrophoresis method using 2% agarose 
gel with Ethidium Bromide and visualized by Gel Doc™ EZ Imager (Bio-rad).   
2.5 Quantitative Real-Time PCR 
To study fold change in gastric differentiation, proliferation or VDR direct 
target genes, quantitative real-time PCR was performed using QuantiStudio® 5 Real-
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Time PCR instrument (Applied Biosystems (ABI)). SYPER green dye was used for 
quantification of dsDNA after every cycle. Specific primers were used as shown in 
table (2.2). PCR reaction volumes of 20 µl were used with 40 amplification cycles. 
Each sample was tested in triplicate. Gene expression levels were calculated using the 
comparative cycle threshold method (ΔΔCT Method) and normalized to GAPDH gene 
expression level.  
2.6 Serum Analysis for Vitamin D  
Blood was collected immediately after sacrifice. Around 1 ml blood samples 
were collected in BD vacutainer (Refe. 367957) and centrifuged 3500 rpm for 15 min 
at 4°C for serum separation and stored in -80 °C. For Serum 25(OH)D analysis, total 
concentration of 25(OH)D (25(OH)D2 + 25(OH)D3) was considered. Liquid 
chromatography tandem-mass spectrometry (LC–MS/MS) was used for measuring 
25(OH)D2 and 25(OH)D3 concentrations. The LC–MS/MS system was comprised of 
a top of the range tandem mass spectrometer, model 8060, in combination with the 
Nexera ultra high-pressure liquid chromatography (UHPLC) system (Shimadzu, 
Japan). 
Prior loading the samples to the LC-MS/MS instrument, extraction step was 
performed. Internal standard solution of 25(OH)D3 (6,9,9-D3) was added to the 
samples. 1 ml hexane:ethyl acetate (9:1) mixture was used for extraction by adding it 
to the sample. The mixture was centrifuged and the organic layer was separated while 
the lower layer was further extracted twice by adding hexane:ethyl acetate (9:1) 
mixture. Calipratnts and quality controls were processed along the sample. They were 
all pooled together and dried at room temperature under sample concentrator. Finally, 
methanol/water (75:25, v/v) mixture was used to re-suspend the residue.       
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2.7 Gastric Acid Content Measurement 
Stomachs collected from the mice on VD3 deficient diet as well as standard 
diet were cut along the greater curvature. The stomachs were rinsed with 1 ml 0.9% 
NaCl (pH 7.0) and to collect clear supernatant the wash was centrifuged at 5000 rpm 
for 10 min. H+ concentration was measured by doing manual titration; the supernatant 
against 0.005 M NaOH. The results were normalized to body weight (Kg). 
2.8 Statistical Analysis 
The statistical analysis was done using Graphpad Prism 7.0.3 to compare the 
different groups. The data was analyzed via one-way ANOVA test, Dannett’s multiple 
comparisons post-test. Data was expressed as means ± SD. p values < 0.05 were 
considered as significant.  
 
 
  
  
 
2
9
 
Table 2.2: Oligonucleotides primers for VDR, CYPs genes, gastric differentiation markers and some vitamin D3 target genes 
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Chapter 3: Results 
Earlier studies identified the stomach as target tissue for 1α,25(OH)2D3by 
applying indirect method and using radioactive labeled vitamin D [82]. Although this 
study is indicating the responsiveness of stomach to vitamin D, the identity of gastric 
epithelial cell expressing VDR has not been illustrated yet in normal gastric tissue.  
In this study, it was possible to characterize specifically the cells expressing 
VDR by following direct method and using specific antibodies for VDR and gastric 
epithelial markers. Additionally, it was possible to find out the possible role of VDR 
in maintaining gastric epithelial homeostasis by studying vitamin D deficiency by 
using vitamin D deficient diet.  
3.1 VDR is Expressed in Normal Gastric Epithelial Tissues 
To find out the normal distribution of VDR in the stomach parts, 
immunolocalization using VDR specific antibody were performed as demonstrated in 
(Figure 3.1).  
The results showed a positive staining for VDR along the cells of corpus gastric 
glands and forestomach of these wild type mice. Nuclear staining as well as 
cytoplasmic staining was detected (Figure 3.1- E and F). The negative control showed 
no signal of DAP (Figure 3.1- C and D). Interestingly, not only the different parts of 
the corpus gastric gland: pit, isthmus, neck and the base were expressing VDR, but 
also the muscular part of the gastric tissue. It is worth mention that Stumpf et al 
illustrated earlier that cells in the isthmus region are selectively and weakly labeled 
with 3H-1,25(OH)2D3 in rat gastric glands [82].    
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Furthermore, in agreement with the immunohistochemistry results, RNA 
analysis of forestomach, corpus and antrum using PCR and specific VDR primers 
confirmed that VDR gene is expressed in these different parts of the stomach (Figure 
3.2). 
3.2 Cytochrome P450 Genes (CYPs) Involved in VD3 Synthesis and Degradation 
are Expressed in the Gastric Epithelial Tissue. 
The expression of CYP2R1, CYP27A1 and CYP27B1; Cytochrome P450 genes 
(CYPs) involved in VD3 synthesis as well as CYP24A1; another Cytochrome P450 
gene involved in breaking down of 1α,25(OH)2D3 had been analyzed in different 
regions of the gastric tissue of mouse (Figure 3.3). 
RT-PCR detected expression of CYP2R1, CYP27A1 and CYP27B1 genes in 
forestomach, corpus and antrum of the wild type mice. Interestingly, expression of 
CYP24A1 gene has been detected only in forestomach region of gastric mucosa. 
The products size corresponded to the expected sizes of the CYPs genes 
amplicons which would have been produced with our primers (Table 2.2).   
This great finding suggests that not only the stomach has the ability to 
synthesize the 1α,25(OH)2D3, but also it can degrade it when necessary. 
3.3 Parietal Cells, Surface Mucous Cells and Mucous Neck Cells Express VDR 
Numerous cells in the corpus gastric glands showed VDR expression with 
different patterns, nuclear and/or cytoplasmic as showed in (Figure 3.1). In order to 
investigate and specify gastric cells expressing VDR, co-immunofluorescence staining 
was performed using antibodies and lectins specific for gastric differentiated cells. 
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The parietal cells showed co-localization of anti-HK β antibody and anti-VDR 
antibody as shown in (Figure 3.4). This co-localization of VDR was nuclear as well as 
cytoplasmic. From this finding we can conclude that some parietal cells are expressing 
VDR. 
Immunostaining of surface mucous cells using UEA lectin showed specific 
staining at the pit region of the corpus gastric glands (Figure 3.5-A). Additionally, we 
can see in Figure 3.5–B that VDR is expressed along the different cells which building 
up the corpus gastric glands. Therefore, to examine whether VDR is expressed in 
surface mucous cells dual immunofluorescence staining was performed. The results 
showed co-staining of UEA lectin and anti-VDR antibody in this type of cells (Figure 
3.5-C), concluding that VDR is expressed in surface mucous cells.  
Mucous neck cells were another corpus gastric gland cells that were assessed 
for VDR expression. GSll lectin, which specifically stain mucous neck cells in the 
gastric mucosa (Figure 3.6-A) as well as anti-VDR antibody (Figure 3.6-B) were 
double stained on the same tissue sections. 
Immunoreactivity of VDR was detected in mucous neck cells, as there was co-
localization of GSII and anti-VDR antibody (Figure 3.6-C). 
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Figure 3.1:Immunohistochemical analysis of the corpus gastric glands showing 
Vitamin D Receptor (VDR) expression. 
Wild type mice (age 2-4 months, n= 3) were sacrificed and stomach was collected. 
(A,C,E) The tissues were from forestomach and (B,D,F,G) corpus parts of the stomach 
of mouse. (A,B)H&E staining. immunoperoxidase staining using Rat polyclonal to 
anti-VDR antibody (dilution1:150, ab115495, abcam) and biotin-SP conjugated goat 
anti-rat IgG (H+L) (112-065-003, Jackson immunoresearch) (E,F,G). Scale bar: 200 
µm. 
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Figure 3.2: VDR mRNA is expressed in the gastric epithelial tissue of C57BL/6J wild 
type mouse. 
RT-PCR detected expression of VDR gene in gastric epithelial tissue of C57BL/6J wild 
type mouse (age 2-4 months, n= 4). The tissues were collected from different parts of 
the stomach (Forestomach, Corpus, antrum). The three different parts of the stomach 
were expressing VDR gene. 
 
 
 
 
 
 
Figure 3.3: Cytochrome P450 genes (CYPs) are expressed in gastric epithelial tissue 
of C57BL/6J wild type mouse. 
The tissues were collected from gastric epithelial tissue of C57BL/6J wild type mouse 
(age 2-4 months, n= 4) different parts of the stomach (Forestomach, Corpus, antrum). 
CYP27A1, CYP2R1 and CYP27B1 genes were expressed in the three different part of 
the stomach. While CYP24A1 gene was expressed only in forestomach.  
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Figure 3.4:Parietal cells of corpus gastric glands are expressing VDR. 
(C) Co-localization of anti-VDR and anti-HK β primary antibody in parietal cells of corpus gastric glands of C57BL/6J wild type mice (age 2-4 
months, n= 3). The histological sections were co-stained with (B) anti-VDR antibody (ab115495, abcam, 1:150 dilution) and (A) anti-HK β primary 
antibody (ab176992, abcam, dilution 1:100). Scale bar: 200 µm. 
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Figure 3.5: Surface mucous cells of corpus gastric glands are expressing VDR. 
(C) Co-localization of anti-VDR and UEA lectin in surface mucous cells of corpus gastric glands of C57BL/6J wild type mice (age 2-4 months, 
n= 3). The histological sections were co-stained with (B) anti-VDR antibody (ab115495, abcam, 1:150 dilution) and (A) lectins UEA-l-Rhodamine 
(RL-1062). Scale bar: 200 µm. 
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Figure 3.6: Mucous neck cells of corpus gastric glands are expressing VDR. 
(C) Co-localization of anti-VDR and GSII lectin in mucous neck cells of corpus gastric glands of C57BL/6J wild type mice (age 2-4 months, n= 
3). The histological sections were co-stained with (B) anti-VDR antibody (ab115495, abcam, 1:150 dilution) and (A) GSII lectin (L21415, Life 
Technologies). Scale bar: 200 µm 
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3.4 A Model of Vitamin D Deficient Mouse is Established. 
To study the impact of VD3 status on gastric epithelium, and gastric cells 
proliferation and differentiation, three groups of mice were fed different diets as 
detailed in (Table 2.1).  
All diets were well tolerated by the mice. Serum levels of total 25(OH)D 
(25(OH)D2 + 25(OH)D3) were used to determine vitamin D status in these three groups 
of mice and reported in nanogram/millitre (ng/ml). Holick classification of vitamin D 
deficiency in human was followed [95]; vitamin D deficiency defined as 25(OH)D of 
<20 ng/ml, vitamin D insufficiency defined as 25(OH)D of 21-29 ng/ml and optimal 
level of 25(OH)D is >30 ng/ml.  
Serum 25(OH)D analysis for SDL, SDD and VDD groups of mice showed that 
low dietary intake of VD3 for 3 months reduced serum 25(OH)D from 33.14 ng/ml in 
the control group to 6.81 ng/ml in VDD group. Interestingly, our results demonstrated 
that vitamin D insufficiency (24.18 ng/ml) can be generated in mice by providing 
normal diet, but eliminating overhead light to prevent endogenous production; detailed 
in (Table 3.1). 
Moreover, the weight of the mice was measured during the 3 months and 
weight gain was observed in VDD group compared to the control, however it was not 
dramatic change (p-value >0.05) (Figure 3.7). This finding was consistant with 
previous studies which linked vitamin D deficiency and overweight/obesity [96].   
Additionally, the mice of the three groups did not suffer from hair loss, and the 
physical activity of all the mice was the same, including the mice which had been kept 
in dark. 
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Table 3.1: The effect of diets containing 1000 IU (standard diet) and 25 UI/Kg VD3 
(VD3  deficient diet) on serum 25(OH)D concentration in mice.  
Three groups of mice (SDL, SDD, VDD) (age ≈ 4 months) were fed different diet for 
a period of 3 months. Blood was collected after sacrifice and total serum 25(OH)D 
concentration (25(OH)D2 + 25(OH)D3) was measured. Serum 25(OH)D concentration 
was represented as Mean (ng/ml) ± SD. One-way ANOVA test was used for data 
analysis. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 
     
Group of Mice N Mean 
(ng/ml)± 
SD 
Vitamin D Status P-value 
Standard Diet 
/Light (SDL) 
10 33.14 ± 5.9 Normal vitamin D  
(25(OH)D > 30 
ng/ml) 
 
NA 
Standard Diet 
/Dark (SDD) 
10 24.18 ± 7.4 vitamin D insufficient 
(25(OH)D of 21-29 
ng/ml) 
** P-value 
=0.0084 
VD3 Deficient Diet 
/Dark (VDD) 
10 6.81 ± 4.5 vitamin D deficient 
(25(OH)D of <20 
ng/ml) 
**** P-value 
=0.0001 
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Figure 3.7: The effect of diets containing 1000 IU VD3 (Standard Diet) and 25 UI/Kg 
VD3 (Vitamin D3 Deficient Diet) on mice weight. 
Standard Diet /light group (SDL), Standard Diet /Dark group (SDD) and vitamin D 
Deficient group of mice (age ≈ 4 months, n= 7/group) were weighted regularly during 
12 weeks. Vitamin D deficient mice gained more weight during the 12 weeks period 
compared to the control group. However, it wasn’t significant. One-way ANOVA test 
was used for data analysis. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001.    
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3.5 Low Vitamin D Status Reduced Gastric Acid Secretion, Relative mRNA 
Expression of HKα and HKβ and Increase Gastrin Expression in Mice. 
The above results indicated that VDR is highly expressed in normal stomach. 
So, it will be necessary to examine the effect of vitamin D deficiency on gastric target 
cells (Figure 3.8 and Figure 3.9).  
Histological examination of gastric mucosa of the VDD, SDD as well as 
control group did not show any noticeable differences among the three groups of mice 
in-term of cells morphology, tissue length and overall tissue structure (Figure 3.8-A). 
Moreover, parietal cells which are the acid secreting cells in gastric mucosa 
were studied. Microscopic examination did not show any morphological changes of 
parietal cells (Figure 3.8-B). However, when relative mRNA expression of HKα and 
HKβ were measured it was found that mRNA expression of the parietal cell marker 
dropped in a significant manner (p-value: 0.0001 and 0.0083 respectively) in vitamin 
D deficient group comparing to the control group (Figure 3.9-A-B).  
Furthermore, H+ concentration in gastric content collected from stomachs of 
fasting mice was measured (Figure 3.9-D). A reduction in H+ concentration was 
observed, and consequently lower gastric acid content in vitamin D deficient mice was 
detected (p-value: 0.09) suggesting that low levels of serum 25(OH)D may reduce acid 
secretion in stomach. It is important to mention that the reduced gastric acid content 
in VDD group correlated with the reduced expression of HK subunits (proton pump).  
It is well known that parietal cells secretion of acid is regulated by gastrin 
hormone [97], so we tested relative mRNA expression of gastrin in the different groups 
of mice. Expectedly, the relative expression of gastrin mRNA significantly increased 
(P-value: 0.0174) in vitamin D deficient group comparing to the control group. There 
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was an increment in gastrin mRNA relative expression in the group of mice kept in 
dark, however, this increment was not significant (p-value: 0.27) compared to the 
control (Figure 3.9- C).   
3.6 Gastric Stem Cells Proliferation Increased in Vitamin D Deficient Mice. 
To further understand the relationship between vitamin D status and stem cells 
proliferation in gastric mucosa of mice, BrdU staining was performed. BrdU 
incorporates with DNA during S phase, detecting newly generated cells.  
BrdU labeled proliferating cells were counted by calculating the mean of BrdU 
positive cells in the corresponding areas of the gastric mucosa of the different groups 
of mice. An increased proliferation in gastric stem cells in the isthmus region of the 
corpus gastric gland was observed in vitamin D deficient mice compared to the control 
group (p-value: 0.004) (Figure 3.10). From this finding we suggest that low vitamin D 
status may increase proliferation rate of normal stem cells in gastric mucosa.  
3.7 Expression of VDR, Gastric Differentiation Markers and 1α,25(OH)2D3 
Target Genes in Normal and Low Vitamin D Level. 
To check the regulatory effect of VD3 on transcription of some genes such as 
VDR, gastric differentiation markers and some target genes of 1α,25(OH)2D3 (PTHLH, 
p21 and TRPV6) in mouse stomach Real-Time PCR was conducted using RNA 
extracted from corpus. 
In mice fed diet with low VD3 level, VDR mRNA expression declined (P-
value: 0.05) compared to the mice in control group (Figure 3.11-A). This result is 
expected since VDR expression is associated to endogenous production of 
1α,25(OH)2D3 as some studies illustrated [98].  
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Figure 3.8: Immunohistochemical analysis of parietal cells showing that size and 
morphology didn’t change with low status of 25(OH)D. 
(A) H&E staining of gastric mucosa of SDL, SDD and VDD group of mice. (B) 
Peroxidase staining of parietal cells of SDL, SDD and VDD group of mice (age ≈ 4 
months, n= 4/group) using anti-HKβ primary antibody (ab176992, abcam, dilution 
1:100) shows no detection of parietal cells atrophy in vitamin D deficient mice. Scale 
bar: 200 µm.  
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Figure 3.9: Low serum 25(OH)D concentration reduces HK sub-units gene expression 
and gastric acid secretion. 
(A-C) Relative mRNA expression of HKα and HKβ significantly decreased, while 
expression of gastrin mRNA increased in VDD mice. (D) Gastric acid content 
decreased in vitamin D3 deficient mice comparing to the normal mice. (age ≈ 4 months, 
n= 7/group). One-way ANOVA test was used for data analysis. *p<0.05, **p<0.01, 
***p<0.001, ****p<0.0001.  
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Figure 3.10: Gastric stem cells proliferation is increased with low serum 25(OH)D 
concentration in mice. 
(A) Immunohistochemical analysis using anti-BrdU antibody (MI-11-3, MBL Life 
Science, dilution 1:500) shows BrdU labeled proliferating cells in isthmus region of 
corpus gastric gland of SDL, SDD and VDD groups of mice (age ≈ 4 months, n= 
4/gorup). Scale bar: 200 µm. (B) Statistical analysis of BrdU labeled cells illustrate an 
increment in number of this cells. One-way ANOVA test was used for data analysis. 
*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001.  
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Next, we investigated mucus secretion in gastric epithelium in case of low and 
normal serum vitamin D level by studying the relative expression of Muc5AC and 
Muc6 genes (markers for surface mucus cells and mucus neck cells respectively). Our 
results showed a very slight decrease in transcription level of these two genes in 
vitamin D deficient mice as well as control dark group compared to the control group 
(Figure 3.11-B&C). We suggest that low serum circulating 25(OH)D slightly decrease 
the secretory activities of surface mucous cells and mucous neck cells or their 
differentiation, and consequently do not impair the gastric mucus secretion. 
Moreover, IF gene expression which is another gastric differentiation marker 
specific for chief cells, showed a remarkable decline (P-value: 0.0309) in the deficient 
group (Figure 3.11-D).   
1α,25(OH)2D3 regulates transcription of several genes through VDRE on the 
promoter of these target genes. PTHLH, TRPV6 and p21 are VD3 target genes which 
are expressed in stomach [44], [52], [48]. When we compared relative mRNA 
expression of these genes in gastric mucosa of vitamin D deficient mice and the control 
group, we noticed a considerable decrease in PTHLH mRNA relative expression (P-
value: 0.002), and a slight decrease in TRPV6 and p21 expression (P-value >0.05) in 
vitamin D deficient mice (Figure 3.12). 
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Figure 3.11: Representative relative mRNA expression of VDR and some gastric 
differentiation markers in normal and low serum 25(OH)D concentration in mice. 
RNA was extracted from corpus of SDL, SDD and VDD groups of mice (age ≈ 4 
months, n= 7/group) and Real-Time PCR was conducted. VDR gene as well as the 
differentiation markers expression is decreased in vitamin D deficient mice compared 
to the control. One-way ANOVA test was used for data analysis.  *p<0.05, **p<0.01, 
***p<0.001, ****p<0.0001.    
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Figure 3.12: Representative relative mRNA expression of some 1,25(OH)2D3 target 
genes in normal and low serum 25(OH)D concentration in mice. 
RNA was extracted from corpus of SDL, SDD and VDD groups of mice (age ≈ 4 
months, n= 7/group) and Real-Time PCR was conducted. Relative mRNA expression 
of PTHLH, TRPV6 and p21 are decreased in vitamin D deficient mice compared to 
the control. One-way ANOVA test was used for data analysis. *p<0.05, **p<0.01, 
***p<0.001, ****p<0.0001. 
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Chapter 4: Discussion 
Several studies evaluated the physiological functions of VDR and VD3 status 
in humans and rodents. Researchers demonstrated earlier that VD3 is involved in 
calcium homeostasis [4], cell differentiation [62] and insulin secretion [78].     
VDR is widely distributed in body tissues and organs. In gastrointestinal tract, 
small Intestine, colon and gastroesophageal junction are expressing VDR [83], [85]. 
Additionally, target tissues of 1α,25(OH)2D3 were detected in stomach [82]. The 
present study clearly showed expression of VDR in different parts of the gastric 
epithelium. Stumph et al demonstrated that only certain cells in rat’s stomach such as 
mucous neck cells and chromaffin cells of the gastric glands are considered target cells 
of 1α,25(OH)2D3 using radioassay [82]. The results in this thesis showed a wide 
distribution of VDR along the corpus gastric glands by using immunohistochemistry 
method. Surface mucous cells, neck mucous cells as well as parietal cells exhibited 
localization of VDR.   
Not only VDR expression was detected, but also CYPs genes which are 
involved in 1α,25(OH)2D3 synthesis and breakdown were found expressed in the 
different parts of the mouse stomach. We found that the corpus and antrum gastric 
glands are specifically expressing CYP2R1, CYP27A1 and CYP27B1, the genes 
encoding for the enzymes responsible of producing the 1α,25(OH)2D3 [23], [27], [21], 
suggesting that these two parts of gastric epithelium have the ability to locally generate 
bioactive VD3.   
It was reported earlier that CYP24A1 gene which encodes for the protein that 
inactivate 1α,25(OH)2D3 [31] is also regulated by 1α,25(OH)2D3 in negative feedback 
loop mechanism through VDRE on the promoter of CYP24A1 [99]. Remarkably, this 
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study showed an expression of CYP24A1 gene exclusively in forestomach (Figure 3.3). 
This finding indicates a significant role of forestomach in breaking down 
1α,25(OH)2D3 when necessary and monitoring local VD3 levels.  
The second part of this study focused on investigating the impact of vitamin D 
deficiency on gastric epithelial cell differentiation and proliferation as well as gastric 
acidity.  
It’s well know that the ion pump HK of parietal cells plays a crucial role in 
gastric acid secretion by exchanging H+ for K. Moreover acid secretion by parietal 
cells is regulated by gastrin hormone [100]. This study reports a decline in gastric 
acidity in vitamin D deficient mice along with lower mRNA expression of HKα and 
HKβ and increased gastrin mRNA expression. An interesting study carried by Antico 
and his team correlated between low serum concentration of 25(OH)D3 and 
Autoimmune Gastritis (AIG) among Italian population, and suggested 
hypovitaminosis D as risk factor for AIG [101]. AIG is caused by auto-production of 
antibodies against HK giving rise to inflammation in gastric mucosa, decreased gastric 
acid secretion as well as mucosal atrophy at the advanced stages [102].   
Furthermore, our results showed a considerable increase in proliferation of 
gastric stem cells in vitamin D deficient group compared to the control (P-value: 0.004) 
(Figure 3.9). Similarly, other studies illustrated that rats fed VD3 deficient diet for 
period of 3 weeks exhibited higher parathyroid cell proliferation compared to rats fed 
normal diet [103]. In another study, VDR knockout mice expressed a significant 
upregulation in Proliferating Cell Nuclear Antigen (PCNA) in the colon compared to 
the wild type mice [104]. Collectively, the results presented in this thesis as well as the 
other studies suggest the importance of vitamin D and VDR in regulating cell 
proliferation. Moreover, higher gastric stem cells proliferation in vitamin D deficient 
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mice might be also linked to higher gastrin expression in this group, since gastrin can 
stimulate cell proliferation [105].  
By conducting Real-Time PCR, we tested the change in relative mRNA 
expression of some gastric differentiation markers such as Muc5AC, Muc6 and IF as 
serum concentration of 25(OH)D3 changed in mice. Our results showed down 
regulation in all of these differentiation markers as 25(OH)D3 concentration decreased, 
however, the change was significant in IF. Concluding that the differentiation of 
surface mucous cells, mucous neck cells and chief cells was reduced due to serum 
25(OH)D3 concentration reduction. These results were consistent with Driel et al 
finding, when he stated that 1α,25(OH)2D3 can induce osteoblast differentiation as he 
was investigating the direct effect of 1α,25(OH)2D3 on osteoblast differentiation and 
mineralization in human osteoblast cell line (SV-HFO) [106]. In contrast to that, Chen 
et al showed an inhibitory role of 1α,25(OH)2D3 treatment on B cells differentiation to 
plasma cells. The expression of the key transcription factors involved in plasma cell 
differentiation didn’t significantly reduced with 1α,25(OH)2D3 treatment. This finding 
suggested that 1α,25(OH)2D3 might have other means to suppress plasma cell 
maturation [5].   
1α,25(OH)2D3  and VDR can regulate transcription of target genes through 
VDRE on their promoter [44]. In the present study, the expression of TRPV6, p21 and 
PTHLH have been examined.  
TRPV6; Transient Receptor Potential Vanilloid member 6, is Ca2+ channel 
which is expressed in stomach and plays role in Ca2+ uptake in GI tract [48], [49]. 
PTHLH and p21 are another 1α,25(OH)2D3 target genes which are expressed in 
stomach. PTHLH is a growth factor regulated by gastrin [107], while p21; Cyclin-
Dependent Kinases Inhibitor is a tumor suppressor that cause cell cycle arrest [52].  
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The current results showed a slight decline in TRPV6 and p21, while a 
significant decrease was reported in PTHLH expression in mice fed VD3 reduced diet 
compared to control mice.  
Pointing to the impact of low serum 1α,25(OH)2D3 concentration on TRPV6 
expression, Walters et al elucidated the positive correlation between duodenum 
TRPV6 expression and serum 1α,25(OH)2D3 level in healthy men, regardless of the 
age. This finding suggested the effect of low 1α,25(OH)2D3 on intestinal calcium 
absorption. However, in healthy women, TRPV6 expression strongly correlated with 
age [108]. On the other, Fleet et al reported constant intestinal TRPV6 expression in 
mice fed low VD3 diet (25 IU/kg) compared to mice fed normal VD3 diet (1000 IU/kg). 
Disclaiming any association between TRPV6 expression level and 1α,25(OH)2D3 
concentration [109].  
Another target gene is p21, which promotes cell cycle arrest [60]. In vitro study 
showed upregulation in p21 and VDR proteins expression in TMK1 cells (Gastric 
Adenocarcinoma cell line) when treated with 1α,25(OH)2D3. A reduction in cell 
number was observed as well. Suggesting anti-proliferative effect of 1α,25(OH)2D3 in 
VDR and p21 dependent manner [110]. In our study, the noticeable upregulation of the 
proliferating cells only in vitamin D deficient mice might be related to the 
downregulation of p21, even-though this downregulation was not significant. 
Mice fed VD3 reduced diet showed considerable downregulation in relative 
mRNA expression of PTHLH in corpus tissue, while gastrin mRNA was upregulated. 
In contrast to our observations, Al Menhali et at found a regulatory role of gastrin on 
PTHLH expression. This regulation was evaluated by increased PTHLH mRNA 
abundance after treating wild type mice with gastrin and decreased PTHLH mRNA 
expression in gastrin-deficient mice [107]. Therefore, we are suggesting that there 
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might be other factors caused reduction in PTHLH expression in VDR and gastrin 
independent mechanism in vitamin D deficient mice.  
54 
 
 
 
Chapter 5: Conclusion and Future Directions 
The present study aimed to investigate the normal expression, distribution and 
cellular localization of VDR in gastric epithelium of C57BL/6 mice. Further, to study 
the expression of the enzymes involved in vitamin D metabolism such as CYP2R1, 
CYP27A1, CYP27B1 and CYP24A1. Since gastric epithelial homeostasis is 
maintained by gastric stem cells proliferation and differentiation, we further aimed to 
study the role of VDR and vitamin D3 in such mechanisms. These aims were achieved 
by performing different morphological and molecular techniques such as 
immunohistochemistry, RT-PCR and Real-Time PCR.  
Our results showed i) the expression of VDR both in protein and mRNA levels 
in the forestomach, corpus and antrum parts of the gastric epithelium of wild type 
C57BL/6 mice, ii) the expression of the enzymes involved in vitamin D metabolism, 
and iii) vitamin D deficient mice were expressing lower HKα, HKβ and higher gastrin 
mRNA, consequently lower gastric acid content compared to the control mice. 
Therefore, it’s very likely that vitamin D deficiency might increase susceptibility of 
having gastric disorders related to decreased gastric acidity. Additionally, acceleration 
in the proliferation of stem cells in isthmus region of the corpus gastric gland was 
observed in vitamin D deficient mice. By investigating the relative mRNA expression 
of some gastric differentiation markers such as Muc5AC, Muc6 and IF in low serum 
vitamin D status, we found a slight decline in Muc5AC and Muc6 expression and 
significant downregulation in IF. To sum up, our study provided data indicating that 
vitamin D and VDR are playing a considerable role in maintaining gastric epithelium 
differentiation and proliferation.   
55 
 
 
 
These approaches hopefully will improve the awareness regarding relationship 
between vitamin D deficiency and gastric diseases such as cancer and minerals 
absorption disorders. As we demonstrated a decline in tumor suppressor p21 and 
calcium channel TRPV6 mRNA expression in vitamin D deficient mice, we suggest to 
provide gastric cancer patients with vitamin D supplements as it has anti-proliferative 
effect to restrict tumor progression. Moreover, to prescribe vitamin D supplement to 
people suffering from gastric malabsorption of calcium due to vitamin D3 deficiency.        
In the current study, mice were fed VD3 deficient diet for only 3 months, so 
this might be a limitation which gave rise to insignificant results in the expression 
some differentiation markers and target genes. Thus, to attain more chronic effect of 
vitamin D deficiency, extending the diet for period of 6 months to 1 year is 
recommended. Considering VD3 deficient diet with high calcium (2%) and high 
phosphate (1.25%) (rescue diet) to avoid hypocalcemia and hyperparathyroidism. 
Furthermore, changing the mice strain to Nude mice might be an option, to allow more 
UV-B radiation penetration to the skin and eliminate hair as barrier in the control 
group. Additionally, it was discovered earlier that  activation of VDR through 
1α,25(OH)2D3 treatment in mice resulted upregulation in cholesterol 7a-hydroxylase 
(CYP7A1) mRNA and reduced level of cholesterol [111]. CYP7A1 is an enzyme 
which can metabolize cholesterol to bile acids in liver [112]. So, in future experiments, 
cholesterol can be measured in serum as well to study the correlation between 
cholesterol and vitamin D deficiency.   
Moreover, to further study the mechanism of VD3 and VDR action in 
maintaining gastric epithelial homeostasis (genetic or non-genetic), in vitro study can 
be conducted by treating mGEP cells with 1α,25(OH)2D3 and VDR antagonist 
(ZK159222); a vitamin D3 analogue which has the ability to prevent VDR interaction 
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with the coactivators and consequently inhibit the genetic response [113], [62]. mGEP 
cell line; Mouse Gastric Epithelial Progenitor, is transgenic cell line established from 
the gastric mucosa of transgenic mouse expressing the simian virus 40 large T antigen 
gene in the parietal cell lineage. These cells will be very beneficial in understanding the 
possible role of vitamin D on gastric cell differentiation and proliferation [114].       
 Furthermore, to expand our findings and understand the role of vitamin D in 
regulating gastric stem cells proliferation, mGEP cells could be treated with different 
doses of 1α,25(OH)2D3 (10-9, 10-8, 10-7 and 10-6 M) and then cell viability test and cell 
count could be performed [115].  
Moreover, we found in the present thesis that the different parts of the stomach 
are expressing the CYPs genes involved in vitamin D metabolism. So, to have better 
understanding of how the stomach can regulate 1α,25(OH)2D3 synthesis and 
degradation independently from liver and kidney, a further experiment including Real-
Time PCR is recommended to check the relative mRNA expression change of 
CYP2R1, CYP27A1, CYP27B1 and CYP24A1 genes in the control group and VDD 
group.   
Finally, in Dr. Asma’s lab, we demonstrated the expression of VDR, Estrogen 
Receptor (ER) as well as Parathyroid Hormone 1 Receptor (PTH1R) in forestomach 
of wild type mice, so more study about this ignored tissue is highly important since 
little is known about it. 
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Appendix  
 
Supplementary table S.1:  Representative table showing the different vitamin D metabolites detected by LC-MS/MS in serum of SDL group of 
mice.  
 
 
 
 
 
 
 
 
 
 
S.NO Sample type volum(uL) 1,25(OH)2-D3 
(ng/ml)
1,25(OH)2-D2 
(ng/ml)
3-EPI-25OHD3 
(ng/ml)
25OHD-3 
(ng/ml)
25OHD-2  
(ng/ml)
25OH(D2+D3)
(ng/ml)
7,C4 
(ng/ml)
VIT D3 
(ng/ml)
VIT D2 
(ng/ml)
1 SDl2 200 12 13 10.4 25 16 41 10 15 0
2 SDL3 150 10 12 22 6.5 28.5 26 24 15
3 SDL4 250 8 30 15 45 6 32 14
4 SDL5 300 3.5 15 10 25 21 40
5 SDL7 150 16 21 11.4 32.4 19 20 5
6 SDL8 150 10 19 15 34 20 6 12
7 SDL9 150 8 8.5 15 27 7 34 6 45
8 SDL12 150 7 6 8 21 13 34 32
9 SDL13 150 15 10 25 5 30 24
10 SDL14 100 5 9 6.3 17.5 15 32.5 8.5 20
Mean 0 0 8.00 9.30 9.91 21.25 11.89 33.14 13.50 23.86 20.88
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Supplementary table S.2:  Representative table showing the different vitamin D metabolites detected by LC-MS/MS in serum of SDD group of 
mice.  
 
 
 
 
 
 
 
 
 
 
 
 
 
S.NO Sample type volum(uL) 1,25(OH)2-D3 
(ng/ml)
1,25(OH)2-D2 
(ng/ml)
3-EPI-25OHD3 
(ng/ml)
25OHD-3 
(ng/ml)
25OHD-2  
(ng/ml)
25OH(D2+D3)
(ng/ml)
7,C4 
(ng/ml)
VIT D3 
(ng/ml)
VIT D2 
(ng/ml)
1 SDD1 150 9 7 3.5 9.5 19 28.5 1.51
2 SDD2 150 2.5 10 12 22 16 25 24
3 SDD5 150 9 10 16 8.5 24.5 3.5 40
4 SDD7 50 12 7 8.8 15.8 4
5 SDD8 50 14 6.5 20.5 7.5 38
6 SDD9 150 17 21.5 38.5 22
7 SDD11 150 16.5 3.5 20 21
8 SDD12 250 11 16 16 32 8
9 SDD13 150 10 6 12 24 36 23
10 SDD15 150 3 20 20 5.5 32
Mean 9.00 8.67 6.86 13.80 12.98 24.18 8.57 28.50 26.57
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Supplementary table S.3:  Representative table showing the different vitamin D metabolites detected by LC-MS/MS in serum of VDD group of 
mice.  
 
 
 
S.NO Sample type volum(uL) 1,25(OH)2-D3 
(ng/ml)
1,25(OH)2-D2 
(ng/ml)
3-EPI-25OHD3 
(ng/ml)
25OHD-3 
(ng/ml)
25OHD-2  
(ng/ml)
25OH(D2+D3)
(ng/ml)
7,C4 
(ng/ml)
VIT D3 
(ng/ml)
VIT D2 
(ng/ml)
1 VDD1 50 3.9 4 7.9
2 VDD2 50 1.8 1.7 3.5
3 VDD3 50 1.3 1.6 2.9 8
4 VDD4 50 1.5 18 18
5 VDD5 50 1.4 1.3 2.7 6
6 VDD6 50 3 3.6 6.6
7 VDD8 50 2.6 0.8 3.4 5.1
8 VDD9 50 0.5 5 5.5 10 9 4
9 VDD12 50 3.6 2 5.6 7 12
10 VDD14 50 9 3 12 2
Mean 1.50 4.51 2.56 6.81 6.75 9.00 6.78
